Evidence map›Paper›PMID 31721989›Full record

Observational studyJAMA dermatology2020

Age-Specific Incidence of Melanoma in the United States.

Kelly G Paulson, Deepti Gupta, Teresa S Kim, Joshua R Veatch, David R Byrd, Shailender Bhatia, Katherine Wojcik, Aude G Chapuis, John A Thompson, Margaret M Madeleine and 1 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in JAMA dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it, 220 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Review
  5. Melanoma incidence in Norway, 1980-2024: a cohort study.The Lancet regional health. Europe · 2026
    Article
  6. Observational
  7. Article
  8. Article
  9. Sun protection behaviors, healthcare access, and smoking among melanoma survivors.Journal of cancer survivorship : research and practice · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Life Factors and Melanoma: From the Macroscopic State to the Molecular Mechanism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  19. Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Kelly G PaulsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Deepti GuptaSeattle Children's Hospital, Seattle, Washington.
Teresa S KimMelanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington.
Joshua R VeatchDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
David R ByrdMelanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington.
Shailender BhatiaDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Katherine WojcikDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Aude G ChapuisDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
John A ThompsonDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Margaret M MadeleineDepartment of Epidemiology, University of Washington School of Public Health, Seattle.
Jennifer M GardnerMelanoma and Skin Oncology, Seattle Cancer Care Alliance, Seattle, Washington.
Fred Hutch Cancer Center · USUniversity of Washington · USSeattle Cancer Care Alliance · USUniversity of Washington Medical Center · USSeattle Children's Hospital · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
TRAINING IN CANCER BIOLOGY &TRANSPLANTATIONT32CA009515 · NCI · UNIVERSITY OF WASHINGTON · PI NANCY ELLEN DAVIDSON, Effie W Petersdorf · 1985 to 2026
$16.2M
Developing Data-Driven Cancer ResearchersT32CA009168 · NCI · UNIVERSITY OF WASHINGTON · PI STEPHEN M SCHWARTZ, MICHAEL Chiao-An WU · 1985 to 2026
$10.1M
Biobehavioral Cancer Prevention and Control Training Program (BCPT)T32CA092408 · NCI · UNIVERSITY OF WASHINGTON · PI Margaret A Hannon · 2016 to 2026
$2.3M
NCI NIH HHS P30 CA015704NCI NIH HHS T32 CA009168NCI NIH HHS T32 CA009515NCI NIH HHS T32 CA092408
6 · The paper itself

Abstract

Importance: Melanoma is epidemiologically linked to UV exposure, particularly childhood sunburn. Public health campaigns are increasing sun-protective behavior in the United States, but the effect on melanoma incidence is unknown. Objective: To examine the incidence of melanoma in the United States and whether any age-specific differences are present. Design, Setting, and Participants: Observational, population-based registry data were extracted on July 3, 2018, from the combined National Program of Cancer Registries-Surveillance Epidemiology and End Results United States Cancer Statistics database for 2001-2015. Deidentified data for 988 103 cases of invasive melanoma, with International Classification of Diseases for Oncology histologic categorization codes 8720 to 8790, were used for analysis. Data analysis was performed from July 1, 2018, to March 1, 2019. Main Outcomes and Measures: The annual rates of melanoma in pediatric, adolescent, young adult, and adult age groups were determined. Analyses were stratified by sex, and incidence rates were age-adjusted to the 2000 US standard population. Annual percentage change (APC) in incidence rate was calculated over the most recent decade for which data were available (2006-2015) using the weighted least squares method. Results: In 2015, 83 362 cases of invasive melanoma were reported in the United States, including 67 in children younger than 10 years, 251 in adolescents (10-19 years), and 1973 in young adults (20-29 years). Between 2006 and 2015, the overall incidence rate increased from 200.1 to 229.1 cases per million person-years. In adults aged 40 years or older, melanoma rates increased by an APC of 1.8% in both men (95% CI, 1.4%-2.1%) and women (95% CI, 1.4%-2.2%). In contrast, clinically and statistically significant decreases were seen in melanoma incidence for adolescents and young adults. Specifically, incidence rates decreased by an APC of -4.4% for male adolescents (95% CI, -1.7% to -7.0%), -5.4% for female adolescents (95% CI, -3.3% to -7.4%), -3.7% for male young adults (95% CI, -2.5% to -4.8%), and -3.6% for female young adults (95% CI, -2.8% to -4.5%). Data on skin pigmentation and sun protection history were unavailable; similar trends were observed with data limited to non-Hispanic whites. Young adult women appeared to have twice the risk of melanoma as young adult men. Conclusions and Relevance: The incidence of invasive melanoma in the United States appeared to decrease in adolescents and young adults from 2006 to 2015, and this finding contrasted with increases in older populations. These incidence trends suggest that public health efforts may be favorably influencing melanoma incidence in the United States.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionAge FactorsChildChild, PreschoolFemaleHumansIncidenceInfantInfant, NewbornMaleMelanomaMiddle Aged

Identifiers

PMID31721989
PMCPMC6865303
OpenAlexW2983347147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.